Acticor Biotech in Les Echos journal

The full article from the French financial newspaper is available here :
Acticor Biotech agit contre l’AVC avec un anticorps monoclonal

Read next in 'Media Coverage'

• "Top 100 startups to invest in" - Challenges Magazine
• Acticor Biotech, a key R&D deal after a successful funding round for the treatment in the acute phase of ischemic stroke
• Biotech Finances: “Twice rewarded Acticor to raise funds again”
• Biotech Finances: “Acticor moves forward and comes back to crowdfunding!”
• BioPharmAnalyses.fr: French crowdfunding supports Acticor Biotech